These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6775807)

  • 1. Pharmacology of tamoxifen in laboratory animals.
    Jordan VC; Allen KE; Dix CJ
    Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
    Jordan VC
    Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
    Jordan VC
    J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
    Robinson SP; Jordan VC
    Cancer Res; 1987 Oct; 47(20):5386-90. PubMed ID: 3115568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL; Mangel WF; Katzenellenbogen BS
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
    Jordan VC
    Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
    Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
    Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of styrylpyrone derivative (SPD) on 7,12-dimethylbenzanthracene-induced rat mammary tumors.
    Hawariah A; Stanslas J
    In Vivo; 1998; 12(4):403-10. PubMed ID: 9706492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
    Janssens JP; Billiet G; Bonte J; De Loecker W
    Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
    Nishino Y; Schneider MR; Michna H
    J Cancer Res Clin Oncol; 1994; 120(5):298-302. PubMed ID: 8126059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.
    Shigaki N; Kimura M; Takano S; Fujino N; Akagi M
    Jpn J Surg; 1987 Sep; 17(5):395-401. PubMed ID: 3123757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S; Stojanovic M; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.